76 research outputs found

    Fission yeast 26S proteasome mutants are multi-drug resistant due to stabilization of the pap1 transcription factor

    Get PDF
    Here we report the result of a genetic screen for mutants resistant to the microtubule poison methyl benzimidazol-2-yl carbamate (MBC) that were also temperature sensitive for growth. In total the isolated mutants were distributed in ten complementation groups. Cloning experiments revealed that most of the mutants were in essential genes encoding various 26S proteasome subunits. We found that the proteasome mutants are multi-drug resistant due to stabilization of the stress-activated transcription factor Pap1. We show that the ubiquitylation and ultimately the degradation of Pap1 depend on the Rhp6/Ubc2 E2 ubiquitin conjugating enzyme and the Ubr1 E3 ubiquitin-protein ligase. Accordingly, mutants lacking Rhp6 or Ubr1 display drug-resistant phenotypes

    Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

    Get PDF
    BACKGROUND: Drug resistance in breast cancer is a major obstacle to successful chemotherapy. In this study we used cDNA microarray technology to examine gene expression profiles obtained from fine needle aspiration (FNA) of primary breast tumors before and after systemic chemotherapy. Our goal was to determine the feasibility of obtaining representative expression array profiles from limited amounts of tissue and to identify those expression profiles that correlate with treatment response. METHODS: Repeat presurgical FNA samples were taken from six patients who were to undergo primary surgical treatment. Additionally, a group of 10 patients who were to receive neoadjuvant chemotherapy underwent two FNAs before chemotherapy (adriamycin 60 mg/m(2) and cyclophosphamide 600 mg/m(2)) followed by another FNA on day 21 after the first cycle. Total RNA was amplified with T7 Eberwine's procedure and labeled cDNA was hybridized onto a 7600-feature glass cDNA microarray. RESULTS: We identified candidate gene expression profiles that might distinguish tumors with complete response to chemotherapy from tumors that do not respond, and found that the number of genes that change after one cycle of chemotherapy was 10 times greater in the responding group than in the non-responding group. CONCLUSION: This study supports the suitability of FNA-derived cDNA microarray expression profiling of breast cancers as a comprehensive genomic approach for studying the mechanisms of drug resistance. Our findings also demonstrate the potential of monitoring post-chemotherapy changes in expression profiles as a measure of pharmacodynamic effect and suggests that these approaches might yield useful results when validated by larger studies

    TET proteins and the control of cytosine demethylation in cancer

    Get PDF

    On the role of intergranular carbides on improving the stress corrosion cracking resistance in a cold-worked alloy 600

    No full text
    The mitigating effect introduced by intergranular Cr carbides on the stress corrosion cracking propagation of a cold-worked Alloy 600 has been firstly examined through high-resolution 3-dimensional (3D) sequential sectioning. High-resolution transmission electron microscope (TEM) and transmission Kikuchi diffraction (TKD) are used to reveal the underlying mechanisms contributing to the mitigating effect. Previously reported mechanisms contributing to the increased stress corrosion cracking resistance are evaluated and discussed. A new mechanism based on grain boundary migration inhibition and crack path deviation is proposed
    corecore